Elektra Health Raises $3.75M for Evidence-Based Menopause Care

Elektra Health Raises $3.75M for Evidence-Based Menopause Care

What You Should Know:

Elektra Health, a new women’s health tech company on a mission to smash the menopause taboo, is announcing $3.75M in seed funding co-led by Alexis Ohanian’s Seven Seven Six and Flare Capital Partners, with participation from City Light Capital, January Ventures, Human Ventures, The Fund, Community Fund, and notable angels including Hannah & Guy Raz, Claire Diaz-Ortiz, Jenny Fielding, and others.

– With a mission to smash the menopause taboo, Elektra is the first full-stack digital platform for women journeying through this phase of their lives, offering users evidence-based education, telemedicine, and text-an-expert support from menopause experts and community members through its proprietary programs.

– In addition to clinical care via telemedicine, Elektra offers its proprietary “Meno-morphosis” program – currently in private beta – featuring evidence-based pathways for managing symptoms, as well as community cohort support and 1:1 access to a dedicated menopause expert.

$600B Global Market Opportunity for Menopause

There’s a $600 billion global market opportunity for menopause, untapped until recently and Elektra is bringing this fragmented space into the 21st century. Menopause is a hormonal health transition that typically starts in the 40s or 50s. There are up to 34 symptoms of menopause, and its impact on women’s quality of life is far-reaching:

– 80% of women experience menopause symptoms that negatively impact their quality of life.

– Women aged 45-64 have the highest suicide rate compared to any other female age group, according to the CDC.

– Over 75% of women experience hot flashes & night sweats.

– Yet <20% of OB/GYN residency programs educate doctors about menopause.

Elektra Health’s three core pillars – education, care, and community – lay the foundation for women to not only understand menopause but to also take actionable steps to optimize their long-term health and wellness. Henderson and Versi are excited to work with investing partners who value women’s physical and mental health and who can help amplify Elektra’s mission.

“Menopause – which represents a $600 billion global market opportunity – is a universal experience that impacts every aspect of a woman’s health: mental, physical, and emotional. It’s a space that has been ignored for years due to social stigma, a fragmented healthcare system, and under-investment in women’s healthcare,” said Alessandra Henderson, Elektra Co-Founder and CEO. “Fortunately, we’re at a turning point. Menopause is finally getting the attention it deserves. Elektra has a big vision to fundamentally change the way that women experience menopause through our proprietary care model and actionable, evidence-based programs. With the backing of top investors, we’re ready to double down on our mission to smash the menopause taboo.”

Traction/Milestones to Date

To date, 1,800+ women have participated in Elektra’s programming.  Elektra Health plans to use the new round of funding to grow the team and to expand its integrative, evidence-based solution to millions of women in the U.S., and beyond.